Alexion Pharmaceuticals, Inc.
ALXNDelisted Jul 21, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000899866
Alexion Pharmaceuticals, Inc. was delisted on Jul 21, 2021; its insiders filed their last Form 4 on Jul 23, 2021; 711 institutions reported holding it in 13F filings for Q2 2021, worth $39.1B in total; superinvestors Soros Fund Management and Maverick Capital held it.
Q3 2021 vs. Q2 2021
How the institutions holding Alexion Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 711 | 8 | 7 | −696 |
| Shares | 212.2M | 1.04M | 5.80K | −211.1M (−100.0%) |
| Value | $39.1B | $191.0M | $823.0K | −$38.9B (−100.0%) |
8 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held Alexion Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Neo Ivy Capital Management | 2,587 | $290.0K | 0.33% |
Sold out (697)
Institutions that held Alexion Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
Showing the largest 100 of 697 by value.
Not filed for Q3 2021 yet (8)
Institutions that held Alexion Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 982,218 | $180.4M |
| Taal Capital Management LP | 50,000 | $9.19M |
| QS Investors, LLC | 7,072 | $1.30M |
| CWM, LLC | 293 | $54.0K |
| First Horizon Corp | 43 | $7.00K |
| Hoover Financial Advisors, Inc. | 35 | $6.00K |
| San Francisco Sentry Investment Group (Ca) | 26 | $5.00K |
| Castleview Partners, LLC | 17 | $3.00K |